Plasma indices of angiogenesis in rheumatoid disease: Relationship to cardiovascular risk factors and cardiac function

International Journal of Cardiology

Volumn 145, Issue 3, 2010, Pages

  Bhatia, Gurbir S ^a   Sosin, Michael D ^a   Patel, Jeetesh V ^a   Grindulis, Karl A ^b   Khattak, Fazal H ^b   Davis, Russell C ^a   Lip, Gregory Y H ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^b SANDWELL GENERAL HOSPITAL   (United Kingdom)

Author keywords

Angiogenesis; Angiogenin; Atherosclerosis.; Cardiovascular risk; Framingham; Rheumatoid; VEGF

Indexed keywords

ANGIOGENIN; CREATININE; CYCLOOXYGENASE 2 INHIBITOR; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; VASCULOTROPIN;

ADULT; ANGIOGENESIS; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART FUNCTION; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATIC DISEASE; STROKE;

BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; COMORBIDITY; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; RHEUMATIC DISEASES; RIBONUCLEASE, PANCREATIC; RISK FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 78649928750     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.12.168     Document Type: Article

References (14)

1. A.E. Koch Angiogenesis as a target in rheumatoid arthritis Ann Rheum Dis 62 Suppl II 2003 60 67
2. D.C. Felmeden, A.D. Blann, and G.Y. Lip Angiogenesis: basic pathophysiology and implications for disease Eur Heart J 24 2003 586 603
3. P.C. Taylor Serum vascular markers and vascular imaging in assessment of rheumatoid arthritis disease activity and response to therapy Rheumatology 44 2005 721 728
4. A. Tello-Montoliu, J.V. Patel, and G.Y. Lip Angiogenin: a review of the pathophysiology and potential clinical applications J Thromb Haemost 4 2006 1864 1874
5. M.L.L. Prevoo, M.A. van't Hof, H.H. Kuper, M.A. van Leeuwen, L.B.A. van de Putte, and P.L.C.M. van Riel Modified disease activity scores that include twenty-eight-joints counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis Arthritis Rheum 38 1995 44 48
6. K.M. Anderson, P.M. Odell, P.W. Wilson, and W.B. Kannel Cardiovascular disease risk profiles Am Heart J 12 1991 293 298
7. I. Pantsulaia, S. Trofimov, E. Kobyliansky, and G. Livshits Genetic and environmental determinants of circulating levels of angiogenin in community-based sample Clin Endocrinol (Oxf) 64 2006 271 279
8. A.D. Blann, F.M. Belgore, C.N. McCollum, S. Silverman, P.L. Lip, and G.Y. Lip Vascular endothelial growth factor and its receptor, Flt-1, in the plasma of patients with coronary or peripheral atherosclerosis, or Type II diabetes Clin Sci 102 2002 187 192
9. D.C. Felmeden, C.G. Spencer, F.M. Belgore, A.D. Blann, D.G. Beevers, and G.Y. Lip Endothelial damage and angiogenesis in hypertensive patients: relationship to cardiovascular risk factors and risk factor management Am J Hypertension 16 2003 11 20
10. F. Chiarelli, M. Pomilio, A. Mohn, S. Tumini, A. Verrotti, and A. Mezzetti Serum angiogenin concentrations in young patients with diabetes mellitus Eur J Clin Invest 32 2002 110 114
11. H. Burgmann, U. Hollenstein, T. Maca, K. Zedwitz-Liebenstein, F. Thalhammer, and R. Koppensteiner Increased serum laminin and angiogenin concentrations in patients with peripheral arterial occlusive disease J Clin Pathol 49 1996 508 510
12. J.V. Silha, M. Krsek, P. Sucharda, and L.J. Murphy Angiogenic factors are elevated in overweight and obese individuals Int J Obes (Lond) 29 2005 1308 1314
13. E.M. Antman, J.S. Bennett, A. Daugherty, C. Furberg, H. Roberts, and K.A. Taubert American Heart Association. Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association Circulation 115 2007 1634 1642
14. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150